Pennsylvania Trails

Product Liability

Arguments Concerning the DePuy ASR Hip System

Posted by on Oct 11, 2013 in Personal Injury, Product Liability | 0 comments

In 2010, DePuy Orthopaedics, a holding company of Johnson & Johnson, recalled the widely used DePuy ASR hip implant. The recall was issued after numerous reports and lawsuits were filed against Johnson & Johnson for defective product design. Many of the recipients of a DePuy ASR hip were badly injured by the implant.

The DePuy ASR ball-and-socket technology was made of cobalt and chromium alloy. The acetabulum shell (socket) and femoral head (ball) were separated by a flimsy polyethylene liner. In many cases, this liner wore down causing the cobalt and chromium to grind against one another. Not only did the grinding pain mimic the arthritic pre-operation condition, but it also put patients at risk for blood toxicity and damaged tissue.

Lawyers representing the victims of a defective DePuy ASR Hip System have mentioned that the scraping action of the metal-on-metal implant can cause damage to the tissue surrounding the joint. This damage can become so extensive that it eventually causes the surrounding tissue to die. Additionally, the scraping of the metal can raise the amount of metal ions in the bloodstream. This alteration to blood levels can affect a patient’s ability to fight infection as well as increase the risk for blood clotting complications.

In addition to physical complications to patients, many lawyers have argued that Johnson & Johnson was aware of the defective qualities of the DePuy hip implant before releasing it for market use. Johnson & Johnson has been accused of inadequate testing, the hiding of failure complaints, and the discarding of redesign efforts. The first federal trial over the DePuy Hip System began in September of 2013. Johnson & Johnson stands to lose around $3 billion dollars if they are held liable for the full extent of the damages.

Read More

A GranuFlo Lawsuit: Compensation for Injury Victims

Posted by on Mar 28, 2013 in GranuFlo, Product Liability | 0 comments

Legal professionals who are versed in the area of medical malpractice know how hard it can be for patients who suffer from the severe complications caused by the drugs doctors prescribe to them. Aside from the physical pain and suffering they may have to endure, patients who suffer injury or illness because of harmful medications may have to cope with costly medical bills and significant psychological and emotional trauma.

One prescription pharmaceutical that has been found to have significant side effects for patients is GranuFlo, manufactured by Fresenius Medical Care. GranuFlo is a dry acid product that is used during dialysis to remove harmful substances from the bloodstream. For a variety of reasons, it was, until recently, one of the most popular products in its category for dialysis patients.

In spite of its relative popularity with physicians and medical facilities, GranuFlo has been linked to a number of serious side effects. Some of these, which have affected thousands of patients across the US, are low blood pressure, cardiac arrest, metabolic alkalosis, heart arrhythmias, stroke, and heart attack; in extreme cases, some patients have even suffered sudden death. In 2010, as many as 941 patients suffered from cardiac arrest due to GranuFlo, prompting the US Food and Drug Administration to issue a Class 1 recall on it, the highest level in the FDA’s recall system.

GranuFlo, a dialysate, is used to cleanse a patient’s blood from the dangerous substances creatinine and urea. This cleansing is done during kidney dialysis, a process performed on patients whose kidneys are no longer capable of removing extra fluid and wastes from their bodies. These extra fluids and wastes are usually removed from the body after the kidneys have converted them to urine.

If you or anyone in your family or circle of friends is suffering from the complications caused by GranuFlo, a Granuflo lawsuit may be the best option for pursuing the financial compensation necessary to deal with the consequences this medical product may have caused.

Read More